Clinical Trial Detail

NCT ID NCT02020707
Title Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Mayo Clinic
Indications

melanoma

Therapies

nab-paclitaxel

Age Groups: adult senior

No variant requirements are available.